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Background: The psychometric properties of Patient Reported Outcomes Measurement Information System (PROMIS)
instruments have been explored in a number of general and clinical samples. No study, however, has evaluated the
psychometric function of these measures in individuals with symptomatic knee osteoarthritis (KOA). The aim of this
project was to evaluate the construct (structural) validity and floor/ceiling effects of four PROMIS measures in this
population.
Methods: We conducted a secondary analysis of baseline data from a randomized trial comparing Tai Chi and physical
therapy. Participants completed four PROMIS static short-form instruments (i.e., Anxiety, Depression, Physical Function, and
Pain Interference) as well as six well-validated (legacy) measures that assess pain, function, and psychological health. We
calculated descriptive statistics and percentages of participants scoring the minimum (floor) and maximum (ceiling)
possible scores for PROMIS and legacy measures. We also estimated the association between PROMIS scores and scores
on legacy measures using Spearman’s rank correlations coefficients.
Results: Data from 204 participants were analyzed. Mean age of the sample was 60 years; 70 % were female. The PROMIS
Anxiety and Depression had floor effects with 17 and 24 % of participants scoring the minimum, respectively. PROMIS
Anxiety and Depression scores had strongest associations with general mental health, including stress (Perceived Stress
Scale, r≥ 0.65) and depression (Beck Depression Index-II, r = 0.70). PROMIS Pain Interference scores correlated most
strongly with measures of whole body pain (Short-Form 36 Bodily Pain, r = −0.73) and physical health (Short-Form 36
Physical-Component Summary, r = −0.73); their correlations were lower with other legacy measures, including with the
WOMAC knee-specific pain (r = 0.47). PROMIS Physical Function scores had stronger associations with scores on the
Short-Form 36 Physical Function (r = 0.79) than with scores on other legacy measures.
Conclusion: The four PROMIS static-short forms performed well among individuals with symptomatic knee osteoarthritis
as evidenced in correlations with legacy measures. PROMIS Anxiety and Depression target general mental health (e.g.,
stress, depression), and PROMIS Pain Interference and Physical Function static-short forms target whole-body outcomes
among participants with symptomatic knee osteoarthritis. Floor effects in the PROMIS Anxiety and Depression scores
should be considered if needing to distinguish among patients with very low levels of these outcomes.
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Osteoarthritis is a disease characterized by structural
changes throughout the joint but it is also an illness of
the whole patient defined by patient-reported outcomes
such as pain, stiffness, and disability [1]. Furthermore, a
patient with osteoarthritis often participates less in val-
ued activities and may experience fatigue as well as dis-
rupted mood, sleep, and quality of life [2–4]. Therefore,
we must measure a wide array of patient-reported out-
comes to thoroughly assess health status and treatment
efficacy among individuals with osteoarthritis.
There are numerous patient-reported outcome measures
to assess individuals with osteoarthritis. Excessive prolifer-
ation of these measures and lack of standardization in
their use, however, hinder comparisons across studies and
populations [5]. Furthermore, using multiple measures
may be time consuming for patients, cost prohibitive, and
not practical for all settings. The National Institutes of
Health’s (NIH) Patient Reported Outcomes Measurement
Information System (PROMIS) has introduced a number
of static short-form patient-reported outcome measures,
which offer an efficient and cost-effective alternative [6].
PROMIS is unique because it is intended for clinicians
and researchers in various disciplines who are inter-
ested in measuring physical, mental, and social health
among individuals with various chronic conditions.
Several static-short form instruments target constructs
relevant to patients with symptomatic knee osteoarth-
ritis, including PROMIS Pain Interference 6b, Physical
Function 10a, Emotional Distress-Anxiety 7a, and Emo-
tional Distress-Depression 8b. Evidence for the validity of
these instruments was initially obtained based on analysis
of responses from a general population sample and from
clinical samples, including a subset with osteoarthritis [7].
However, no prior study has evaluated the properties of
PROMIS static short-form scores among individuals with
symptomatic knee osteoarthritis.
Our objective was to evaluate the floor/ceiling effects
and construct (structural) validity of four PROMIS Short-
Form Instruments (i.e., Pain Interference 6b, Physical
Function 10a, Emotional Distress-Anxiety 7a, and Emo-
tional Distress-Depression 8b) function among a well-
characterized sample of individuals with knee osteo-
arthritis. To achieve our goals we asked participants to
complete six legacy measures: Medical Outcomes Short
Form-36 (SF-36) [8–10], the Western Ontario and McMas-
ter Universities Arthritis Index (WOMAC) [11–13], two
objective physical function tests (i.e., 6-min walk test,
20-meter walk test) [14], the Perceived Stress Scale
[15], and the Beck Depression Inventory Second Edi-
tion (BDI-II) [16–19]. These measures of pain, function,
and psychological health domains were chosen because
they relate to the constructs measured by the four
PROMIS static short-form instruments and are widelyused and well-validated among individuals with knee
osteoarthritis.Methods
We conducted a secondary analysis of baseline data ob-
tained in our NIH-funded, randomized trial that compared
Tai Chi and physical therapy among individuals with symp-
tomatic knee osteoarthritis (Trial Registry #NCT01258985)
[20]. This secondary dataset is unique because it includes
responses to a wide range of patient-reported outcome
measures, both PROMIS measures and well-validated (leg-
acy) measures used widely in studies of knee osteoarthritis.
Data were collected at Tufts Medical Center, an urban ter-
tiary care academic hospital in Boston, USA. We received
ethics approval for this study from the Tufts Medical Cen-
ter/ Tufts University Human Institutional Review Board.
To be eligible, participants had to meet the following
criteria: 1) age ≥40 years; 2) Western Ontario and McMas-
ter Universities Arthritis Index (WOMAC) pain subscale
score (100 mm visual analog scales) >40 on at least 1 out
of 5 questions; 3) fulfillment of the American College of
Rheumatology criteria for knee osteoarthritis [21]; 4)
radiographic evidence of knee osteoarthritis defined as the
presence of osteophytes in the tibiofemoral and/or the
patellofemoral compartment, as assessed on standing
anterior-posterior and lateral views; and 5) confirmation
of knee pain, discomfort, or disability by clinical examin-
ation. We excluded individuals who had experience in the
past year with physical therapy, Tai Chi training, or similar
types of alternative medicine (e.g., Qi Gong or yoga); ser-
ious medical conditions limiting their ability to fully
participate as determined by a primary care physician;
intra-articular steroid injections or replacement surgery
on the affected knee in the previous three months; or a
Mini-Mental examination score <24. All participants en-
rolled in the study provided informed consent. For this
secondary analysis, we included all 204 participants who
had their baseline visits between March 2011 and June
2013. These 204 participants were selected after staff pre-
screened almost 1,200 individuals on the phone and then
screened approximately 280 individuals in person. The
most common reason a person was not randomized into
the study was if the individual failed to meet the inclusion
criteria or an individual declined to participate.PROMIS instruments
Participants enrolled in the trial completed four PROMIS
static short-form, version 1.0 instruments including PRO-
MIS Pain Interference 6b, Physical Function 10a, Emotional
Distress-Anxiety 7a, and Emotional Distress-Depression 8b.
These PROMIS instruments were the original versions of
the short forms. The instruments were selected to meet the
goal of the parent study: to compare the influence of Tai
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come measures.
The validity of PROMIS instruments has been assessed
in both general and clinical U.S. sample populations
[7, 22–24]. PROMIS short forms represent the items of
the PROMIS item banks constructed to measure the tar-
geted constructs. All of the included PROMIS short forms
used 5-point Likert-type response categories to capture
intensity, frequency, or duration, described in detail below.
The instruments use a seven-day recall period, with the
exception of PROMIS Physical Function, which does not
reference any timeframe.
PROMIS instruments are publicly available on the PRO-
MIS Assessment Center Library website: http://www.as-
sessmentcenter.net/PromisForms.aspx. Sample questions
are available at http://www.nihpromis.org/measures/Sam-
pleQuestions. Scoring manuals for PROMIS measures
(http://www.assessmentcenter.net/Manuals.aspx) outline
the development of the short forms (also see http://
www.nihpromis.org/science/sciencehome), report psycho-
metric properties for each instrument, and describe how
to identify PROMIS T-scores based on short form raw
summed item scores. For all of the PROMIS short forms
we reported the PROMIS T-scores.
PROMIS Short Form v1.0 - Pain Interference 6b mea-
sures “impact of pain on physical, mental, and social activ-
ities” (6). It consists of 6 items measured on a 5-point
Likert-type scale (first 5 questions: “not at all” to “very
much”; final question: “never” to “always”). The questions
assess the degree to which pain interferes with enjoyment
in life, ability to concentrate, day-to-day activities, recre-
ational activities, tasks away from home, and socializing
with others. The scores range from 41 to 78.3 with higher
scores representing worse pain impact.
PROMIS Short Form v1.0 - Physical Function 10a mea-
sures “ability to carry out various activities that require
physical capability, ranging from self-care to more vigor-
ous activities that require increasing degrees of mobility,
strength, or endurance” [7]. Half the 10 items of this form
address the degree to which the respondent’s health limits
physical activities such as carrying groceries, climbing
stairs, or participating in sports (“not at all” to “cannot
do”). The other five items address the level of difficulty
faced in carrying out activities of daily living such as
vacuuming or tying one’s shoelace (“without any difficulty”
to “unable to do”). The scores range from 14.1 to 61.7
with higher scores representing better functioning.
PROMIS Short Form v1.0 - Emotional Distress- Anxiety
7a measures “fear, anxious misery, hyperarousal, and som-
atic symptoms related to arousal” [7]. The instrument con-
sists of 7 items that ask respondents about the frequency
with which they experienced emotions such as fear, stress,
and anxiety (“never” to “always”). Scores range from 36.3
to 82.7 with higher scores indicating worse anxiety.PROMIS Short Form v1.0 - Emotional Distress - De-
pression 8b measures “negative mood, decrease in positive
affect, information processing deficits, negative views of
the self, and negative social cognition” [7]. It consists of 8
items in which respondents indicate the frequency with
which they have experienced emotions such as worthless-
ness, hopelessness, and sadness (“never” to “always”).
Scores range from 35.2 to 82.4 with higher scores repre-
senting worse depression.
Legacy measures
The SF-36 is a measure of general health status comprised
of eight scales: physical functioning, social functioning,
bodily pain, energy and vitality, mental health, role limita-
tions due to physical problems, role limitations due to emo-
tional problems, and general health. The eight scales are
summarized in the Physical Component Summary (PCS)
and Mental Component Summary (MCS) scores. The SF-
36 uses a 4-week recall period and consists of 36 items.
Scores range from 0 to 100 with higher scores indicating
better health. The SF-36 has been used widely in clinical
osteoarthritis trials and the validity of SF-36 scores as a
measure of health status has been well documented [8–10].
The WOMAC is a disease-specific measure designed to
evaluate joint-specific health status and health outcomes
in knee and hip osteoarthritis. We used the form consist-
ing of 100 mm horizontal visual analogue scales with a
48-h recall period. It has three subscales: pain (score
range, 0–500), stiffness (0–200), and function (0–1700)
with higher subscale scores indicating more severe disease.
The validity of WOMAC has been well-established in
knee and hip osteoarthritis [11–13].
The 6-min walk test and 20-m walk test are performance-
based measures of gait velocity used to assess lower ex-
tremity function and mobility. The 6-min walk test is a
measure of distance walked (measured in meters), while
walking as fast as possible, in a total of six minutes, with
greater distances indicating higher capacity. The 20-m
walk test is a measure of time (measured in seconds) re-
quired to walk a total of twenty meters, with longer times
indicating lower capacity. Both tests were performed in
quiet hallways and were administered by trained investiga-
tors following a standard script. Gait velocity measures are
valid for use in knee osteoarthritis populations [14].
The Perceived Stress Scale is a measure of non-specific
stress appraisal. It uses a 1-month recall period and con-
sists of 10 items on a 5-point Likert scale. Scores range
from 0 to 40 with higher scores indicating higher levels of
experienced stress. The validity of Perceived Stress Scale
scores has been well documented in knee osteoarthritis
studies [15].
The BDI-II is a measure of depression that assesses
commonly associated signs and symptoms according the
Diagnostic and Statistical Manual of Mental Disorders,
Table 1 Demographic and clinical characteristics of patients
with knee osteoarthritis (n = 204)
Characteristic Distribution
n (%)a
Age, mean ± SD years 60.2 (10.5)
Body Mass Index, mean ± SD kg/m2 32.8 (7.2)
Self-reported duration of knee pain, median
(25th, 75th percentile) years
5.0 (3.0, 10.0)
Tibiofemoral Kellgren/Lawrence grade≥ 2 183 (92.4)






Greater than high school education 170 (83.3)
an (%) unless noted otherwise. SD = standard deviation
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consists of 21 multiple-choice items. Scores range from
0 to 63 with higher scores indicating more severe de-
pression. The BDI-II has been validated for use among
non-psychiatric populations and has been used to assess
depression in multiple knee osteoarthritis studies [16–19].
Procedure
As part of their baseline assessment and prior to any
intervention, participants completed the outcome mea-
sures described above. The outcome measures were
completed in the following order: WOMAC, SF-36, Per-
ceived Stress Scale, BDI-II, PROMIS Pain Interference,
PROMIS Physical Function, PROMIS Depression, and
PROMIS Anxiety. All of the self-reported outcome mea-
sures were collected and managed using REDCap elec-
tronic data capture tools [25] hosted at Tufts Medical
Center except for WOMAC, which was completed on
paper. The two physical function tests were completed
on site and were administered either prior to or after
completion of the questionnaires, depending on the
availability of research staff.
Statistical analysis
The analyses reported here was limited to baseline data
obtained from participants that met eligibility criteria
and were enrolled in the study. We calculated descrip-
tive statistics and percentages of participants scoring the
minimum (floor) and maximum (ceiling) possible scores.
We defined important floor or ceiling effects as more
than 15 % of participants achieving the lowest or highest
score, respectively [26]. Because not all data were nor-
mally distributed, we estimated the association between
scores on the PROMIS instruments and legacy measures
using the non-parametric, Spearman’s rank correlation
coefficient.
Comparison of results with previous literature
Tests of the statistical significance of differences in associ-
ations were outside the scope of this study and observed
differences in point estimates of correlations should not
be over-interpreted. However, to provide an interpretive
context for our results, we presented the current results in
the context of previous correlational studies. We con-
ducted a comprehensive literature search (in Summer
2014) for articles that reported correlations between
scores from legacy measures and PROMIS scores or other
instruments that measure similar constructs. Results
gleaned from published literature were grouped by clinical
status: general population, osteoarthritis, other clinical
conditions, and the current study results. Findings were
plotted by condition on a graph to visually represent the
range of findings in previous studies.Results
Demographic data and descriptive statistics
Our analysis included data from 204 participants with
an average age of 60 years and body mass index of
33 kg/m2 (Table 1). Ninety-two percent had a Kellgren/
Lawrence grade ≥ 2 in the tibiofemoral joint with a me-
dian self-reported duration of knee pain of 5 years.
Table 1 includes additional demographic and clinical
characteristics for the sample.
Floor or ceiling effects are reported in Table 2. Add-
itional file 1: Table S1 and Figs. 1 and 2 report the cor-
relation coefficients between PROMIS static short-form
instruments and legacy measures.
PROMIS pain interference
PROMIS Pain Interference demonstrated minimal floor
effect with only 5 % of participants scoring the mini-
mum PROMIS Pain Interference score. Pain Interference
scores had stronger correlations with measures of whole
body pain (SF-36 Bodily Pain, r = −0.73, 95 % confidence
interval [CI] = −0.79 to −0.65) and physical health (SF-36
PCS, r = − 0.73, 95 % CI = −0.79 to −0.66) than other
legacy measures, including knee-specific pain (WOMAC
pain, r = 0.47, 95 % CI = 0.35 to 0.57) or gait speed (20-
m walk test, r = 0.34, 95 % CI = 0.21 to 0.45.
PROMIS physical function
PROMIS Physical Function scores had no floor effect
since all of the participants scored above the minimum
but one participant reported the highest possible score.
PROMIS Physical Function scores had stronger correla-
tions with measures of whole body function than with
other legacy measures, including patient-reported lower
extremity function or objective measures of lower ex-
tremity performance. Specifically, PROMIS Physical
Table 2 Descriptive statistics of outcome measures in patients with knee osteoarthritis including floor and ceiling effects
Outcome Measure Scores Floor Ceiling
Score Range n Mean ± SD Median (range) n % n %
PROMIS Pain Interference 41-78.3 204 58.0 (7.0) 58.1 (41.0-74.4) 11 5.4 0 0
PROMIS Physical Functiona 14.1-61.7 204 40.7 (5.5) 40.2 (28.8-61.7) 0 0 1 0.5
PROMIS Anxiety 36.3-82.7 203 50.2 (8.9) 51.3 (36.3-72.9) 34 16.8 0 0
PROMIS Depression 37.1-81.1 202 48.9 (8.9) 48.2 (37.1-77.9) 49 24.3 0 0
SF-36 PCSa 0-100 204 36.6 (9.1) 36.7 (14.0-59.8) 0 0 0 0
SF-36 MCSa 0-100 204 52.5 (9.2) 54.5 (21.6-68.1) 0 0 0 0
SF-36 Bodily Paina 0-100 204 47.5 (18.6) 41.0 (0.0-100.0) 1 0.5 4 2.0
SF-36 Physical Function 0-100 204 52.0 (22.2) 50.0 (0.0-100.0) 2 1.0 3 1.5
WOMAC Pain 0-500 203 254 (98.6) 239.8 (50.7-500.0) n/a n/a 1 0.5
WOMAC Function 0-1700 204 899.0 (352.4) 906.7 (218.6, 1700.0) 0 0 1 0.5
6-min Walk Testab (meters) n/a 199 395.5 (90.1) 392.8 (89.1-645.3) n/a n/a n/a n/a
20-Meter Walk Testa (seconds) n/a 202 19.0 (5.3) 18.2 (9.6-66.8) n/a n/a n/a n/a
PSS 0-40 203 13.3 (7.0) 13.0 (0.0, 37.0) 5 2.5 0 0
BDI-II 0-63 199 7.6 (8.6) 5.0 (0.0-39.0) 27 13.6 0 0
PROMIS = Patient Reported Outcomes Measurement Information System (reported as T-scores); SF-36 =Medical Outcomes Short Form-36, MCS =Mental Component
Summary, PCS = Physical Component Summary, BP = Bodily Pain; WOMAC =Western Ontario and McMaster Universities Arthritic Index; PSS = Perceived Stress
Scale; BDI-II = Beck Depression Index II
aHigher scores indicate better health-related outcomes (for other measures, higher scores indicates worse health-related outcomes)
bDoes not include patients who refused, or attempted and failed
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Function (r = 0.79, 95 % CI = 0.73 to 0.84) compared
with WOMAC function (r = −0.48, 95 % CI = −0.58 to
−0.36), gait speed (r = −0.43, 95 % CI = −0.53 to −0.31), or
6-min walk times (r = 0.46, 95 % CI = 0.34 to 0.56).PROMIS anxiety
PROMIS Anxiety scores had a floor effect; 17 % of partici-
pants scored the minimum. For comparison, 3 % of partic-
ipants had a minimum Perceived Stress Scale score.
PROMIS Anxiety scores had stronger correlations with
measures of stress (r = 0.71, 95 % CI = 0.64 to 0.77) and
depression (r = 0.70, 95 % CI = 0.62 to 0.76) than other
legacy measures. For example, PROMIS Anxiety scores
had small to moderate correlations with measures of func-
tion (r = −0.40 to 0.17) and pain (r = −0.41 and 0.20).
PROMIS depression
PROMIS Depression scores also had a floor effect; 24 %
of participants scored the minimum. For comparison,
14 % of participants had a minimum BDI-II score. PRO-
MIS Depression scores had stronger correlations with
measures of stress (r = 0.65, 95 % CI = 0.56 to 0.72) and
depression (r = 0.70, 95 % CI = 0.62 to 0.76) than with
other legacy measures. For example, PROMIS Depres-
sion scores had small to moderate correlations with
measures of physical function (r = −0.31 to 0.11) and
pain (SF-36 Bodily Pain: r = −0.31 and WOMAC knee
pain: r = 0.19).Comparison to previous literature
Figure 1 (PROMIS Pain Interference and Physical Func-
tion) and Fig. 2 (PROMIS Depression and Anxiety) visu-
ally locate the current study results in the range of
findings from previous studies. In general, the values ob-
tained in the current study were similar both to those
obtained in other studies of individuals with osteoarth-
ritis and in studies using other samples. As already
noted, tests of the statistical significance of differences in
associations were outside the scope of this study, and
observed differences in point estimates should not be
over-interpreted. We did note some putative differences
that could warrant additional study (see Additional file 1:
Table S1, Figs. 1 and 2). Pairs of measures that generated
lower correlation estimates in the current study compared
to previous studies included: a) PROMIS Pain Interference
scores and SF-36 Bodily Pain scores, and b) PROMIS Phys-
ical Function scores with the WOMAC Pain, WOMAC
Function, SF-36 Physical Function, and gait speed. Pairs of
measures that generated higher correlation estimates in the
current study compared to previous studies included: a)
PROMIS Pain Interference scores and scores on patient-
reported mental health scores (e.g., SF-36 MCS, BDI-II)
and b) PROMIS Physical Function scores on the same
measures.
Discussion
PROMIS is a novel system of free instruments that clini-
cians and researchers in various medical disciplines can
use. The PROMIS static short-forms offer an efficient and
Fig. 1 Correlations between Anxiety and Depression and Legacy Measures. References for the correlations are provided in the supplementary file. To
develop a reference set of correlations we considered correlations between scores from legacy measures and PROMIS scores or other instruments that
measure similar constructs. SF-36 = short form 36, PF = physical function, PCS = physical component score, MCS =mental component score, BP = bodily
pain, PSS = Perceived Stress Scale, BDI-II = Beck Depression Inventory – II, and 6MWT= 6-min walk test
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comes critical to the assessment of knee osteoarthritis.
This is the first study to evaluate the performance of the
PROMIS static short-form instruments specifically among
participants with symptomatic knee osteoarthritis. We
found that PROMIS Anxiety and Depression measure a
similar construct to other patient-reported outcomes that
assess general mental health, including stress and depres-
sion, among patients with symptomatic knee osteoarth-
ritis. The PROMIS Anxiety and Depression had a floor
effect but the implications of this for future studies de-
pend on study goals. For clinicians and researchers inter-
ested in distinguishing among individuals with low levels
of anxiety or depression, the PROMIS short forms would
not be a good choice. For example, if a researcher wished
to explore an intervention’s impact on depression or anx-
iety by investigating whether it would benefit individuals
with anxiety below the US mean then the short formsmay not be ideal. The floor effect could impede detection
of a treatment effect. However, these floor effects might be
unimportant in a study of a clinical population in which the
presence of anxiety and depression has been documented.
The associations we found between scores on PROMIS
measures and legacy measures suggest that the PROMIS
Pain Interference and Physical Function scores target
whole body pain and physical function among individuals
with symptomatic knee osteoarthritis. Recently, Broderick
et al. demonstrated known-groups validity (a subtype of
construct validity) of the computer adaptive administra-
tions of PROMIS Pain Interference and Physical Function
in a study comparing patients with osteoarthritis to the
general population [27]. Our results complement and ex-
pand upon those of Broderick et al., specifically among
individuals with symptomatic knee osteoarthritis. Our find-
ings indicate that PROMIS Pain Interference and Physical
Function have stronger correlations with assessments of
Fig. 2 Correlations between Pain Interference (PI) and Physical Function (PF) and Legacy Measures. References for the correlations are provided in
the supplementary file. To develop a reference set of correlations we considered correlations between scores from legacy measures and PROMIS
scores or other instruments that measure similar constructs. SF-36 = short form 36, PF = physical function, PCS = physical component score, MCS
=mental component score, BP = bodily pain, PSS = Perceived Stress Scale, BDI-II = Beck Depression Inventory – II, and 6MWT = 6-min walk test
Driban et al. BMC Musculoskeletal Disorders  (2015) 16:253 Page 7 of 9whole-body disease burden (i.e., SF-36 Bodily Pain, SF-36
PCS) compared to joint-specific measures (i.e., WOMAC
pain, WOMAC function, and physical function tests). Con-
ceptually, this is expected since the two PROMIS static
short-form instruments include questions that are not
lower-extremity specific.
During the initial item-evaluation process of the full
PROMIS Physical Function item bank, the data satisfied
criteria for unidimensionality, suggesting that the four
subdomains of mobility (lower extremity), dexterity (upper
extremity), axial or central (neck or back), and complex
activities could be collapsed into one domain [28]. Bruce
et al. pointed out however, that the analysis was con-
ducted among individuals with relatively little disease
burden compared with the typical clinical trial partici-
pant, raising the question of whether the unidimen-
sional model can be applied among other populations.
After the data used in the current study were collected,Hays, et al. [29] identified upper-extremity and mobility
subdomains of PROMIS Physical Function data. The two
subdomains shared 35 % of the variance in common. Sub-
sets of items targeting these two subdomains were identi-
fied and scored using PROMIS parameters. This work
allows measurement of upper-extremity function and mo-
bility as well as overall physical functioning within the
PROMIS system. Clinicians and researchers, who are
interested in the local effects of knee osteoarthritis, may
prefer using PROMIS lower-extremity items [29] or a
joint-specific pain and function outcome (e.g., WOMAC).
However, if the goal is to assess whole body pain or func-
tion (e.g., assessing an exercise intervention among pa-
tients with osteoarthritis at the knee and other joints)
then the short form may be appropriate. Ultimately, many
investigators or clinicians may want to consider lower-
extremity specific outcomes and whole body changes.
Therefore, using a computer adaptive version of PROMIS
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taneous assessment of whole-body and lower-extremity
specific outcomes, which would reduce the number of
outcome instruments a participants needs to complete
and reduce study expenses associated with paying for mul-
tiple patient-reported outcomes.
Our study is limited. Our visual representation of correl-
ation results from the current study and previous research
highlighted some observable differences in point estimates
of associations. It was outside the scope of this study to
evaluate whether these putative differences were signifi-
cantly different or accountable to random variation. First,
because the order of outcome measure administration was
consistent across participants, order bias and patient fa-
tigue may have affected patients’ responses to self-report
measures and performance on physical function tests.
Second, our analyses did not include patients who re-
fused or attempted and failed the two physical function
tests (6-min walk test [n = 4]; 20-m walk test [n = 2]).
Because patients who attempted and failed the physical
function tests represent the extremes of functional im-
pairment, our analysis overestimates the overall func-
tion of our cohort. However, this subgroup represents a
small proportion of our overall sample and thus we did
not feel this significantly influenced our overall results.
Third, our definition of floor and ceiling effects was likely
a conservative estimate. We measured the number of pa-
tients with the minimum and maximum scores rather
than clinically-defined scores with thresholds representa-
tive of the extremes of health-related outcomes. Longitu-
dinal studies will be needed to assess the minimally
important change to better estimate the floor and ceiling
effects.
More work needs to be done to understand the role of
PROMIS static short-form instruments in evaluating pa-
tients with knee osteoarthritis. Future studies might assess
time savings and cost efficiency, as well as other key
psychometric properties as outlined by the Consensus-
based Standards for the Selection of Health Measurement
Instruments (COSMIN) [30]; including, responsiveness of
scores on PROMIS short-forms in detecting change and
score interpretability among patients with knee osteoarth-
ritis. Lastly, computerized-adaptive administrations of
PROMIS instruments should also be tested among pa-
tients with knee osteoarthritis.
Conclusions
In conclusion, scores on the four tested PROMIS static
short forms demonstrated good performance among pa-
tients with symptomatic knee osteoarthritis as evidenced
in correlations with legacy measures. The patterns of cor-
relations suggest that PROMIS Anxiety and Depression
targets general mental health (e.g., stress, depression), and
PROMIS Pain Interference and Physical Function staticshort forms target whole body outcomes (e.g., SF-36)
among participants with symptomatic knee osteoarthritis.
These instruments may be useful in clinical research
among individuals with symptomatic knee osteoarthritis.
However, floor effects in the PROMIS Anxiety and Depres-
sion scores should be considered if needing to distinguish
among patients with very low levels of these outcomes.
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